UBcare. Co. Ltd (032620) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.001x

Based on the latest financial reports, UBcare. Co. Ltd (032620) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩184.89 Million ≈ $125.29K USD) by net assets (₩159.99 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 032620 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

UBcare. Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how UBcare. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

UBcare. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of UBcare. Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Lhyfe SA
PA:LHYFE
-0.190x
Severn Trent PLC
LSE:SVT
0.224x
Havila Kystruten AS
OL:HKY
-0.034x
icad inc
NASDAQ:ICAD
0.002x
Bixolon Co. Ltd
KQ:093190
0.047x
Bionet
TWO:1784
0.013x
FG Merger II Corp. Common stock
NASDAQ:FGMC
0.006x
Bank of the James Financial Group
NASDAQ:BOTJ
0.024x

Annual Cash Flow Conversion Efficiency for UBcare. Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of UBcare. Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see UBcare. Co. Ltd (032620) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩158.89 Billion
≈ $107.68 Million
₩16.63 Billion
≈ $11.27 Million
0.105x +342.05%
2024-12-31 ₩99.22 Billion
≈ $67.24 Million
₩2.35 Billion
≈ $1.59 Million
0.024x +7.93%
2023-12-31 ₩113.54 Billion
≈ $76.94 Million
₩2.49 Billion
≈ $1.69 Million
0.022x -39.77%
2022-12-31 ₩116.70 Billion
≈ $79.09 Million
₩4.25 Billion
≈ $2.88 Million
0.036x -45.93%
2021-12-31 ₩117.89 Billion
≈ $79.89 Million
₩7.94 Billion
≈ $5.38 Million
0.067x -39.01%
2020-12-31 ₩106.52 Billion
≈ $72.19 Million
₩11.76 Billion
≈ $7.97 Million
0.110x -3.89%
2019-12-31 ₩102.57 Billion
≈ $69.51 Million
₩11.79 Billion
≈ $7.99 Million
0.115x +39.13%
2018-12-31 ₩101.66 Billion
≈ $68.90 Million
₩8.40 Billion
≈ $5.69 Million
0.083x -58.86%
2017-12-31 ₩46.55 Billion
≈ $31.55 Million
₩9.35 Billion
≈ $6.33 Million
0.201x +198.71%
2016-12-31 ₩46.56 Billion
≈ $31.55 Million
₩3.13 Billion
≈ $2.12 Million
0.067x -60.94%
2015-12-31 ₩45.31 Billion
≈ $30.70 Million
₩7.80 Billion
≈ $5.28 Million
0.172x +30.76%
2014-12-31 ₩39.49 Billion
≈ $26.76 Million
₩5.20 Billion
≈ $3.52 Million
0.132x +4.66%
2011-12-31 ₩47.23 Billion
≈ $32.01 Million
₩5.94 Billion
≈ $4.02 Million
0.126x --

About UBcare. Co. Ltd

KQ:032620 Korea Software & IT Services
Market Cap
$106.24 Million
₩156.76 Billion KRW
Market Cap Rank
#19052 Global
#915 in Korea
Share Price
₩3080.00
Change (1 day)
-3.14%
52-Week Range
₩2970.00 - ₩4330.00
All Time High
₩12880.42
About

UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more